Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

XOMA XOMA Corporation

-0.70 (-2.70%)
May 22 2024 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 9,886
Bid Price 15.77
Ask Price 27.88
News -
Day High 26.32


52 Week Range


Day Low 25.52
Company Name Stock Ticker Symbol Market Type
XOMA Corporation XOMA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.70 -2.70% 25.20 17:30:02
Open Price Low Price High Price Close Price Prev Close
25.70 25.52 26.32 25.20 25.90
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
374 9,886 $ 25.92 $ 256,257 - 13.48 - 27.00
Last Trade Time Type Quantity Stock Price Currency
19:34:51 1 $ 25.87 USD

XOMA Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
301.57M 11.63M - 4.76M -40.83M -3.51 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »


Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No XOMA Message Board. Create One! See More Posts on XOMA Message Board See More Message Board Posts

Historical XOMA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week25.6726.3224.2625.2314,067-0.47-1.83%
1 Month26.1426.7523.6925.2810,401-0.94-3.60%
3 Months24.1927.0023.0025.2815,3651.014.18%
6 Months15.9527.0014.3321.2021,7959.2557.99%
1 Year19.2927.0013.4818.6728,7865.9130.64%
3 Years31.6939.0213.4821.2029,793-6.49-20.48%
5 Years16.9046.3213.4823.2839,2878.3049.11%

XOMA Description

XOMA Corp is a biotechnology royalty aggregator playing a unique role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.

Your Recent History

Delayed Upgrade Clock